List of Tables
Table 1. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-Vascular Endothelial Growth Factor Therapeutic Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-Vascular Endothelial Growth Factor Therapeutic, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-Vascular Endothelial Growth Factor Therapeutic, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-Vascular Endothelial Growth Factor Therapeutic, Product Type & Application
Table 12. Global Key Manufacturers of Anti-Vascular Endothelial Growth Factor Therapeutic, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-Vascular Endothelial Growth Factor Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Vascular Endothelial Growth Factor Therapeutic as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Region (2019-2024)
Table 19. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Region (2025-2030)
Table 21. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2019-2024)
Table 53. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Type (2025-2030)
Table 54. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-Vascular Endothelial Growth Factor Therapeutic Price (US$/Unit) by Type (2019-2024)
Table 59. Global Anti-Vascular Endothelial Growth Factor Therapeutic Price (US$/Unit) by Type (2025-2030)
Table 60. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2019-2024)
Table 63. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Application (2025-2030)
Table 64. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-Vascular Endothelial Growth Factor Therapeutic Price (US$/Unit) by Application (2019-2024)
Table 69. Global Anti-Vascular Endothelial Growth Factor Therapeutic Price (US$/Unit) by Application (2025-2030)
Table 70. Regeneron Pharmaceuticals Corporation Information
Table 71. Regeneron Pharmaceuticals Description and Business Overview
Table 72. Regeneron Pharmaceuticals Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Regeneron Pharmaceuticals Anti-Vascular Endothelial Growth Factor Therapeutic Product
Table 74. Regeneron Pharmaceuticals Recent Developments/Updates
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bayer Anti-Vascular Endothelial Growth Factor Therapeutic Product
Table 79. Bayer Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Novartis Anti-Vascular Endothelial Growth Factor Therapeutic Product
Table 84. Novartis Recent Developments/Updates
Table 85. Roche Corporation Information
Table 86. Roche Description and Business Overview
Table 87. Roche Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Roche Anti-Vascular Endothelial Growth Factor Therapeutic Product
Table 89. Roche Recent Developments/Updates
Table 90. Biogen Corporation Information
Table 91. Biogen Description and Business Overview
Table 92. Biogen Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Biogen Anti-Vascular Endothelial Growth Factor Therapeutic Product
Table 94. Biogen Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Anti-Vascular Endothelial Growth Factor Therapeutic Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Coherus BioSciences Corporation Information
Table 101. Coherus BioSciences Description and Business Overview
Table 102. Coherus BioSciences Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Coherus BioSciences Anti-Vascular Endothelial Growth Factor Therapeutic Product
Table 104. Coherus BioSciences Recent Developments/Updates
Table 105. Amgen Corporation Information
Table 106. Amgen Description and Business Overview
Table 107. Amgen Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Amgen Anti-Vascular Endothelial Growth Factor Therapeutic Product
Table 109. Amgen Recent Developments/Updates
Table 110. Bausch Health Companies Corporation Information
Table 111. Bausch Health Companies Description and Business Overview
Table 112. Bausch Health Companies Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Bausch Health Companies Anti-Vascular Endothelial Growth Factor Therapeutic Product
Table 114. Bausch Health Companies Recent Developments/Updates
Table 115. Viatris Corporation Information
Table 116. Viatris Description and Business Overview
Table 117. Viatris Anti-Vascular Endothelial Growth Factor Therapeutic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Viatris Anti-Vascular Endothelial Growth Factor Therapeutic Product
Table 119. Viatris Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Anti-Vascular Endothelial Growth Factor Therapeutic Distributors List
Table 123. Anti-Vascular Endothelial Growth Factor Therapeutic Customers List
Table 124. Anti-Vascular Endothelial Growth Factor Therapeutic Market Trends
Table 125. Anti-Vascular Endothelial Growth Factor Therapeutic Market Drivers
Table 126. Anti-Vascular Endothelial Growth Factor Therapeutic Market Challenges
Table 127. Anti-Vascular Endothelial Growth Factor Therapeutic Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Vascular Endothelial Growth Factor Therapeutic
Figure 2. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Share by Type in 2023 & 2030
Figure 4. Aflibercept (Eylea) Product Picture
Figure 5. Ranibizumab (Lucentis) Product Picture
Figure 6. Brolucizumab (Beovu) Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Share by Application in 2023 & 2030
Figure 10. Macular Edema
Figure 11. Diabetic Retinopathy
Figure 12. Retinal Vein Occlusion
Figure 13. Age-related Macular Degeneration
Figure 14. Others
Figure 15. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Size (2019-2030) & (US$ Million)
Figure 17. Global Anti-Vascular Endothelial Growth Factor Therapeutic Sales (2019-2030) & (K Units)
Figure 18. Global Anti-Vascular Endothelial Growth Factor Therapeutic Average Price (US$/Unit) & (2019-2030)
Figure 19. Anti-Vascular Endothelial Growth Factor Therapeutic Report Years Considered
Figure 20. Anti-Vascular Endothelial Growth Factor Therapeutic Sales Share by Manufacturers in 2023
Figure 21. Global Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Anti-Vascular Endothelial Growth Factor Therapeutic Players: Market Share by Revenue in 2023
Figure 23. Anti-Vascular Endothelial Growth Factor Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Anti-Vascular Endothelial Growth Factor Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Country (2019-2030)
Figure 26. North America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country (2019-2030)
Figure 27. United States Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Country (2019-2030)
Figure 30. Europe Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country (2019-2030)
Figure 31. Germany Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Region (2019-2030)
Figure 38. China Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Country (2019-2030)
Figure 46. Latin America Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Anti-Vascular Endothelial Growth Factor Therapeutic Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Anti-Vascular Endothelial Growth Factor Therapeutic by Type (2019-2030)
Figure 56. Global Revenue Market Share of Anti-Vascular Endothelial Growth Factor Therapeutic by Type (2019-2030)
Figure 57. Global Anti-Vascular Endothelial Growth Factor Therapeutic Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Anti-Vascular Endothelial Growth Factor Therapeutic by Application (2019-2030)
Figure 59. Global Revenue Market Share of Anti-Vascular Endothelial Growth Factor Therapeutic by Application (2019-2030)
Figure 60. Global Anti-Vascular Endothelial Growth Factor Therapeutic Price (US$/Unit) by Application (2019-2030)
Figure 61. Anti-Vascular Endothelial Growth Factor Therapeutic Value Chain
Figure 62. Anti-Vascular Endothelial Growth Factor Therapeutic Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
